The company must pay nearly $450 million for illegally blocking generic competition to the testosterone product with “baseless” patent litigation, a judge said.
Pharmaceutical Care
Management Association
505 9th Street NW, 10th Floor, Washington, DC 20004
© 2025 PCMA. All Rights Reserved.